OBERWEIS ASSET MANAGEMENT INC/ - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
OBERWEIS ASSET MANAGEMENT INC/ ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2018$137,000
+31.7%
17,100
+22.1%
0.03%
+25.9%
Q1 2018$104,000–14,000–0.03%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q1 2018.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders